Carbon-ion radiotherapy for marginal lymph node recurrences of cervical cancer after definitive radiotherapy: a case report

被引:5
|
作者
Tamaki, Tomoaki [1 ]
Ohno, Tatsuya [1 ]
Kiyohara, Hiroki [1 ]
Noda, Shin-ei [1 ]
Ohkubo, Yu [1 ]
Ando, Ken [1 ]
Wakatsuki, Masaru [2 ]
Kato, Shingo [3 ]
Kamada, Tadashi [2 ]
Nakano, Takashi [1 ]
机构
[1] Gunma Univ, Grad Sch Med, Dept Radiat Oncol, Maebashi, Gunma 3718511, Japan
[2] Natl Inst Radiol Sci, Res Ctr Charged Particle Therapy, Inage Ku, Chiba 2638555, Japan
[3] Saitama Med Univ Int Med Ctr, Hidaka, Saitama 3501298, Japan
关键词
Carbon-ion radiotherapy; Marginal recurrences; Cervical cancers; RADIATION-THERAPY; UPDATE;
D O I
10.1186/1748-717X-8-79
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Recurrences of cervical cancer after definitive radiotherapy often occur at common iliac or para-aortic lymph nodes as marginal lymph node recurrences. Patients with these recurrences have a chance of long-term survival by optimal re-treatment with radiotherapy. However, the re-irradiation often overlaps the initial and the secondary radiotherapy fields and can result in increased normal tissue toxicities in the bowels or the stomach. Carbon-ion radiotherapy, a form of particle beam radiotherapy using accelerated carbon ions, offers more conformal and sharp dose distribution than X-ray radiotherapy. Therefore, this approach enables the delivery of high radiation doses to the target while sparing its surrounding normal tissues. Marginal lymph node recurrences in common iliac lymph nodes after radiotherapy were treated successfully by carbon-ion radiotherapy in two patients. These two patients were initially treated with a combination of external beam radiotherapy and intracavitary and interstitial brachytherapy. However, the diseases recurred in the lymph nodes near the border of the initial radiotherapy fields after 22 months and 23 months. Because re-irradiation with X-ray radiotherapy may deliver high doses to a section of the bowels, carbon-ion radiotherapy was selected to treat the lymph node recurrences. A total dose of 48 Gy (RBE) in 12 fractions over 3 weeks was given to the lymph node recurrences, and the tumors disappeared completely with no severe acute toxicities. The two patients showed no evidence of disease for 75 months and 63 months after the initial radiotherapy and for 50 months and 37 months after the carbon-ion radiotherapy, respectively. No severe late adverse effects are observed in these patients. The two presented cases suggest that the highly conformal dose distribution of carbon-ion radiotherapy may be beneficial in the treatment of marginal lymph node recurrences after radiotherapy. In addition, the higher biological effect of carbon-ion radiotherapy and its superior dose distribution may provide more effective tumor control in treatment for re-irradiation of the marginal recurrences in radiation resistant tumors other than cervical cancer.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Clinical Impact of Re-irradiation with Carbon-ion Radiotherapy for Lymph Node Recurrence of Gynecological Cancers
    Shiba, Shintaro
    Okonogi, Noriyuki
    Kato, Shingo
    Wakatsuki, Masaru
    Kobayashi, Daijiro
    Kiyohara, Hiroki
    Ohno, Tatsuya
    Karasawa, Kumiko
    Nakano, Takashi
    Kamada, Tadashi
    ANTICANCER RESEARCH, 2017, 37 (10) : 5577 - 5583
  • [22] Laparoscopic liver resection for local recurrence after carbon-ion radiotherapy for hepatocellular carcinoma: A case report
    Tanaka, Tomokazu
    Ide, Takao
    Itoh, Kotaro
    Kai, Keita
    Noshiro, Hirokazu
    ONCOLOGY LETTERS, 2024, 27 (02)
  • [23] Carbon ion radiotherapy for bladder cancer: A case report
    Zhang, Yan-Shan
    Li, Xiao-Jun
    Zhang, Yi-He
    Hu, Ting-Chao
    Chen, Wei-Zuo
    Pan, Xin
    Chai, Hong-Yu
    Wang, Xin
    Yang, Yu-Ling
    WORLD JOURNAL OF CLINICAL CASES, 2021, 9 (26) : 7833 - 7839
  • [24] Carbon ion radiotherapy for bladder cancer: A case report
    Yan-Shan Zhang
    Xiao-Jun Li
    Yi-He Zhang
    Ting-Chao Hu
    Wei-Zuo Chen
    Xin Pan
    Hong-Yu Chai
    Xin Wang
    Yu-Ling Yang
    World Journal of Clinical Cases, 2021, (26) : 7833 - 7839
  • [25] Carbon-ion radiotherapy for locoregional recurrence after primary surgery for pancreatic cancer
    Kawashiro, Shohei
    Yamada, Shigeru
    Isozaki, Yuka
    Nemoto, Kenji
    Tsuji, Hiroshi
    Kamada, Tadashi
    RADIOTHERAPY AND ONCOLOGY, 2018, 129 (01) : 101 - 104
  • [26] The size of the metastatic lymph node is an independent prognostic factor for the patients with cervical cancer treated by definitive radiotherapy
    Song, Sanghyuk
    Kim, Joo-Young
    Kim, Yeon-Joo
    Yoo, Heon Jong
    Kim, Sun Ho
    Kim, Suk-Ki
    Lim, Myong Cheol
    Kang, Sokbom
    Seo, Sang-Soo
    Park, Sang-Yoon
    RADIOTHERAPY AND ONCOLOGY, 2013, 108 (01) : 168 - 173
  • [27] Conversion surgery for an initially unresectable, locally advanced pancreatic cancer after induction chemotherapy and carbon-ion radiotherapy: a case report
    Fujishiro, Takeshi
    Mashiko, Taro
    Masuoka, Yosihito
    Yamada, Misuzu
    Furukawa, Daisuke
    Yazawa, Naoki
    Kawashima, Yohei
    Ogawa, Masami
    Hirabayashi, Kenichi
    Nakagohri, Toshio
    SURGICAL CASE REPORTS, 2018, 4
  • [28] Radiation-Induced Osteosarcoma in the Cervical Spine after Definitive Radiotherapy for Esophageal Cancer: A Case Report
    Toriumi, Kensuke
    Miyamoto, Hiroshi
    Ikeda, Terumasa
    Akagi, Masao
    SPINE SURGERY AND RELATED RESEARCH, 2020, 4 (04): : 374 - 376
  • [29] Predictors of Outcomes in Patients With Clinically Lymph Node Positive Prostate Cancer After Definitive Radiotherapy
    Kim, Tae Hyun
    Kim, Dong-Yun
    Kim, Jae-Sung
    IN VIVO, 2023, 37 (05): : 2365 - 2370
  • [30] Conversion surgery for an initially unresectable, locally advanced pancreatic cancer after induction chemotherapy and carbon-ion radiotherapy: a case report
    Takeshi Fujishiro
    Taro Mashiko
    Yosihito Masuoka
    Misuzu Yamada
    Daisuke Furukawa
    Naoki Yazawa
    Yohei Kawashima
    Masami Ogawa
    Kenichi Hirabayashi
    Toshio Nakagohri
    Surgical Case Reports, 4 (1)